newsfilter
← Latest News
PR Newswire·

Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress

Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for...